Breast Cancer Coverage from Every Angle
Advertisement
Advertisement

Lee S. Schwartzberg, MD, on Biomarkers and Gene Assays

Posted: Friday, March 24, 2017

Lee S. Schwartzberg, MD, of The University of Tennessee Health Science Center, discusses the role of biomarkers and available multigene assays in guiding clinical decisions on breast cancer treatment.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.